Nymox Pharmaceutical Corp (NYMX) Reports Q1 EPS of $0.07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts NYMX Hot Sheet
Join SI Premium – FREE
Nymox Pharmaceutical Corp (NASDAQ: NYMX) reported Q1 EPS of $0.07, versus ($0.03) reported last year. Revenue for the quarter came in at $78.16 thousand, versus $184.25 thousand reported last year.
For earnings history and earnings-related data on Nymox Pharmaceutical Corp (NYMX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Curtiss-Wright CFO to retire, controller named interim replacement
- Penguin Solutions names Stephen Cumming as CFO
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
